Concepedia

Sara Zaknoen

SZ

24

Publications

3.5K

Citations

21

H-Index

1985

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Tracon Pharmaceuticals (United States)

Royal Marsden Hospital

Duke Medical Center

National Cancer Institute

Sara Zaknoen is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

1985–2021

24

Publications

24

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

W.K. Alfred Yung, Robert E. Albright, Jeffrey J. Olson et al. · British Journal of Cancer · 2000 · 932 citations · Full text

Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

W.K. Alfred Yung, Michael D. Prados, Ricardo Yayá et al. · Journal of Clinical Oncology · 1999 · 757 citations

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

M. Brada, Khê Hoang‐Xuan, R. Rampling et al. · Annals of Oncology · 2001 · 369 citations · Full text

, , +8

Phase II Trial of Temozolomide in Patients With Progressive Low-Grade Glioma

Jennifer A. Quinn, David A. Reardon, Allan H. Friedman et al. · Journal of Clinical Oncology · 2003 · 254 citations

The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia

Waldmann Ta, JD White, C K Goldman et al. · Blood · 1993 · 206 citations · Full text

Rows per page

1–5 of 24